Disinfection of bacteriophages products using supercritical carbon dioxide
Inventors
Assignees
Precisionbiotix Technologies Inc • Precisio Biotix Therapeutics Inc
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
There is proposed a method for the sterilization of products containing bacteriophages in a manner that will allow the bacteriophages to retain their activity and infectivity. Products containing bacteriophages are exposed to supercritical CO2 under conditions causing little or no damage to structural integrity of the bacteriophages or to the structural properties of biodegradable scaffolds containing the bacteriophages.
Core Innovation
The invention relates to a method for producing a disinfected product including bioactive bacteriophages infectious for predetermined bacteria, where the disinfected product is usable in a target environment. The method provides an initial product in which the bioactive bacteriophages are present in an initial quantity and protects at least partially the bioactive bacteriophages from degradation by supercritical carbon dioxide (scCO2) by lyophilizing, immobilizing on a polymer, and/or encapsulating in microcapsules inside a hydrophobic layer to provide the bacteriophages in an anhydrous environment.
After protection, the initial product is contacted with a disinfection fluid including scCO2 for a disinfection duration between 30 to 120 minutes under disinfection conditions, where the pressure is between 8 MPa and 11 MPa and the temperature is between 31° C. and 38° C. The bioactive bacteriophages are present in a final quantity in the disinfected product, where the final quantity is effective for producing lysis of the predetermined bacteria to reduce bacterial content in the target environment when the disinfected product is used in the target environment.
The approach further specifies polymer matrices for protecting and maintaining bacteriophage infectivity in an anhydrous environment, including polymers selected from poly (ester amide urea), poly (ester urethane urea), poly (ester amide urethane urea), poly (ester amide urethane), poly (ester urea), and poly (ester urethane). These polymers are defined by diol, diacid, and amino acid linkages through ester bond, amide bond, urethane bond, and urea bond, including defined formula selections for the diol and diacid and natural and non-naturally occurring amino acids.
Claims Coverage
Two independent claims are identified, and both center on protecting bioactive bacteriophages from scCO2 degradation while enabling disinfection by contacting with scCO2 for defined durations, pressures, and temperatures, using anhydrous polymer-based formats and specified polymer classes.
Producing a disinfected product with scCO2-protected bioactive bacteriophages
Providing an initial product having bioactive bacteriophages infectious for predetermined bacteria, protecting at least partially the bioactive bacteriophages from degradation by scCO2 by lyophilizing and/or immobilizing on a polymer and/or encapsulating in microcapsules inside a hydrophobic layer to provide the bacteriophages in an anhydrous environment, and contacting the initial product with a disinfection fluid including scCO2 for a disinfection duration between 30 to 120 minutes at a pressure of between 8 MPa and 11 MPa and at a temperature of between 31° C. and 38° C., wherein the bioactive bacteriophages are present in a final quantity effective for producing lysis of the predetermined bacteria to reduce bacterial content in the target environment.
Eliminating or reducing bacterial contamination by scCO2 exposure of an anhydrous polymer-borne bacteriophage composition
Exposing the product including a bacteriophage containing composition to scCO2, wherein the bacteriophage containing composition includes bioactive bacteriophages after exposition to scCO2 and includes bacteriophages dispersed in a polymer and/or bacteriophages immobilized on a polymer to provide the bacteriophages in an anhydrous environment, and treating the bacteriophage containing composition with scCO2 between about 9 MPa and about 10 MPa at between about 31° C. and about 38° C. and for between about 30 min and about 120 min, with the polymer selected from poly (ester amide urea), poly (ester urethane urea), poly (ester amide urethane urea), poly (ester amide urethane), poly (ester urea), and poly (ester urethane).
Across both independent claims, the main inventive features are protecting bioactive bacteriophages from scCO2 degradation using lyophilizing, immobilizing on a polymer, and/or encapsulating in microcapsules inside a hydrophobic layer to provide an anhydrous environment, and performing scCO2 disinfection with specified pressure, temperature, and duration to obtain a disinfected product where bioactive bacteriophages remain to enable lysis of predetermined bacteria. Both claims are additionally grounded in specific polymer families defined by ester, amide, urethane, and urea linkages and defined diol, diacid, and amino acid selections.
Stated Advantages
Preservation of bioactive bacteriophage infectivity after scCO2 disinfection.
Reduction of bacterial content in the target environment when the disinfected product is used.
Gentle processing via scCO2 disinfection while retaining useful bacteriophage activity.
Useful shelf life (stated advantage in the provided partial content).
Near elimination of microbes (stated advantage in the provided partial content).
Documented Applications
Disinfected product usable in a target environment, where the bioactive bacteriophages are effective for producing lysis of predetermined bacteria to reduce bacterial content in that target environment.
Eliminating or reducing bacterial contamination of a product using a bacteriophage containing composition exposed to scCO2, including embodiments where bacteriophages are adsorbed, adhered, or otherwise immobilized on an exposed implant surface for implantation in a human or animal body.
Treatment of a bacteriophage containing composition with scCO2 in combination with a sterilant additive selected from acetic acid, tert-butyl hydroxy peroxide, paracetic acid, ethanol, formic acid, or hydrogen peroxide, as an option described for improving CO2 penetration through bacterial cellular membranes.
Interested in licensing this patent?